Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hjelte

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The European Respiratory Journal|February 3, 2005
Long-term clearance from small airways in patients with cystic fibrosisM Lindström, P Camner, R Falk, et al.
Acta Paediatrica Scandinavica|February 1, 1991
Decreased renal clearance of sodium in cystic fibrosisP Stenvinkel, L Hjelte, G Alván, et al.
Clinical and Experimental Immunology|May 5, 2017
Vitamin D treatment modulates immune activation in cystic fibrosisT Pincikova, D Paquin-Proulx, J K Sandberg, et al.
European Journal of Clinical Nutrition|December 15, 2016
Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trialT Pincikova, D Paquin-Proulx, J K Sandberg, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1989
Comparison of efficacy and tolerance of intravenously and orally administered ciprofloxacin in cystic fibrosis patients with acute exacerbations of lung infectionB Strandvik, L Hjelte, A Lindblad, et al.
Clinical Genetics|January 15, 2000
Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in SwedenC Schaedel, L Hjelte, I de Monestrol, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 2, 2001
Arbitrarily primed PCR and sequencing of 16S rDNA for epidemiological typing and species identification of Burkholderia cepacia isolates from Swedish patients with cystic fibrosis reveal genetic heterogeneityF Karpati, V Giedraitis, M Thore, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patientsB A Christensson, I Nilsson-Ehle, B Ljungberg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 24, 2009
Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patientsG Fluge, H V Olesen, M Gilljam, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 11, 2011
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group reportT Pressler, C Bohmova, S Conway, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The European Respiratory Journal|February 3, 2005
Long-term clearance from small airways in patients with cystic fibrosisM Lindström, P Camner, R Falk, et al.
Acta Paediatrica Scandinavica|February 1, 1991
Decreased renal clearance of sodium in cystic fibrosisP Stenvinkel, L Hjelte, G Alván, et al.
Clinical and Experimental Immunology|May 5, 2017
Vitamin D treatment modulates immune activation in cystic fibrosisT Pincikova, D Paquin-Proulx, J K Sandberg, et al.
European Journal of Clinical Nutrition|December 15, 2016
Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trialT Pincikova, D Paquin-Proulx, J K Sandberg, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1989
Comparison of efficacy and tolerance of intravenously and orally administered ciprofloxacin in cystic fibrosis patients with acute exacerbations of lung infectionB Strandvik, L Hjelte, A Lindblad, et al.
Clinical Genetics|January 15, 2000
Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in SwedenC Schaedel, L Hjelte, I de Monestrol, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 2, 2001
Arbitrarily primed PCR and sequencing of 16S rDNA for epidemiological typing and species identification of Burkholderia cepacia isolates from Swedish patients with cystic fibrosis reveal genetic heterogeneityF Karpati, V Giedraitis, M Thore, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patientsB A Christensson, I Nilsson-Ehle, B Ljungberg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 24, 2009
Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patientsG Fluge, H V Olesen, M Gilljam, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 11, 2011
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group reportT Pressler, C Bohmova, S Conway, et al.
Pageof 5